Preliminary results from PiSARRO, a phase Ib/II study of APR-246, a mutant p53 reactivating small molecule, in combination with standard chemotherapy in platinum-sensitive ovarian cancer

File Description SizeFormat 
aacr poster JAG.docxAccepted version369.59 kBMicrosoft WordView/Open
Title: Preliminary results from PiSARRO, a phase Ib/II study of APR-246, a mutant p53 reactivating small molecule, in combination with standard chemotherapy in platinum-sensitive ovarian cancer
Authors: Von Euler, M
Wiman, KG
Gabra, H
Brenton, JD
Basu, B
Vergote, I
Gourley, C
Smith, A
Alfredsson, J
Mohelll, N
Green, JA
Item Type: Conference Paper
Issue Date: 1-Aug-2015
Date of Acceptance: 18-Apr-2015
URI: http://hdl.handle.net/10044/1/51018
DOI: https://dx.doi.org/10.1158/1538-7445.AM2015-CT204
ISSN: 1538-7445
Publisher: American Association for Cancer Research
Journal / Book Title: Cancer Research
Volume: 75
Copyright Statement: © 2015 American Association for Cancer Research.
Sponsor/Funder: Ovarian Cancer Action
Funder's Grant Number: N/A
Conference Name: 106th Annual Meeting of the American-Association-for-Cancer-Research (AACR)
Keywords: Science & Technology
Life Sciences & Biomedicine
Oncology
1112 Oncology And Carcinogenesis
Oncology & Carcinogenesis
Publication Status: Published
Start Date: 2015-04-18
Finish Date: 2015-04-22
Conference Place: Philadelphia, PA
Appears in Collections:Division of Surgery
Division of Cancer
Faculty of Medicine



Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.

Creative Commonsx